Panelists will explore the current state of cannabis legalization in various regions throughout the Americas and highlight emerging markets with high growth potential. Attendees will leave this panel with a deeper understanding of the current state and future potential of emerging cannabis markets in the Americas, as well as insights and strategies for success in these exciting and rapidly evolving markets.
Medical Cannabis: Overview of Emerging Legal Issues and their Impact on the International Market. The international panel of experts will notably discuss the differences in regulations between medical cannabis and pharmaceutical cannabis, how IP is becoming an essential topic with pharmaceutical cannabis medicines, and how it could also impact medical cannabis in the short run.
Join our panelists for an honest and supportive discussion about harm reduction, stress management, and mental health among attorneys. Learn how to support colleagues in recovery or who are struggling – and how to recognize and manage these challenges in yourself. Discuss how to make colleagues understand that attorney wellness is not merely a buzzword or a generational difference; it is directly related to competence to practice and meeting duties to clients.
Interstate Commerce in Statehouses and the Courts: What Will Ultimately Bring About the Onset of Interstate Sales? At least four states have seen legislative action involving ways that interstate commerce can be triggered prior to full federal legalization, namely California, Oregon, New Jersey, and blank. This panel will explore the potential triggers that could unlock interstate sales, as well as how the lack of movement at the federal level factors into states' decision-making and operators' risks.
Interstate Commerce in Practice: What will Interstate commerce actually look like, and how will it be regulated? Assuming interstate commerce will commence before federal legalization, this session will probe the nuances of the federal government's posture toward state-regulated interstate sales will impact how products can effectively move from state to state. Presenters will discuss the practical challenges for regulators and operators in establishing an efficient and well-regulated interstate market.
Risky Business: Managing Risk Within a Cannabis Company. From insurance to human resources to employment to governance, an effective risk management policy can save money, prevent liability and put your cannabis company in a position for success. These experts will explore all the aspects of effective risk management within a cannabis company.
Here Comes the Money: Banking and Payment Processing in the Cannabis Industry. Banking and payment processing has long been one of the most misunderstood aspects of operating within the cannabis industry. This panel of experts will explore the current state of banking and payments in cannabis and how to utilize these services legally.
In this course, attendees will examine the interconnectedness of social equity initiatives and basic legal principles (i.e. justice, equity, etc.) This program will encourage diversity of thought, give cannabis attorneys more to consider when advising diverse populations and ask participants to walk a mile in a social equity applicant's shoes. Attendees will leave this course with a deeper understanding (and appreciation) of why social equity programs exist, including their role in undoing the harms of cannabis prohibition, how they serve diverse clients and promote equal access to justice, and why social equity programs are necessary.
Cannabis law and policy continue to quickly evolve and the past year has seen major legal developments for the regulated marijuana and hemp industries. Moderated by Paul Demko, Cannabis Editor at POLITICO, this panel of experts bring their broad legal and policy perspectives to identify and comment upon important court rulings and litigation trends, as well as anticipated changes to the law heading into 2024 on a variety of legal topics.
In this session the panelists will discuss international hemp-derived products trade. More specifically, the panelists will offer an overview of what transatlantic trade of hemp-derived products (food products, cosmetic products, vaping products…) for consumer use looks like with a particular focus on import and export of these products from the US market to the EU and/or the UK market(s) and from the EU and/or the UK to the USA.